Susan Ziolkowski

Onco-nephrologist at Stanford

[Susan Ziolkowski @ZiolkowskiSusan]

our new study: patients who are treated with Orca-T cell therapy may have better long term kidney outcomes compared to patients who received standard allogeneic stem cell transplant with methotrexate for GvHD prophylaxis
https://t.co/RsGbjDHuTn
#Onconephrology #cellulartherapy

[Susan Ziolkowski @ZiolkowskiSusan]

oncology and nephrology providers: please fill out stanford survey on VEGF inhibitor use to help improve kidney care in cancer patients! @ASCO @MSKCancerCenter @JCO_ASCO @TheLancetOncol @myESMO @StanfordCancer

https://t.co/4W4hznx2Ym

[Susan Ziolkowski @ZiolkowskiSusan]

oncology and nephrology providers: please fill out our survey on VEGFi use!

https://t.co/4W4hznx2Ym

[Susan Ziolkowski @ZiolkowskiSusan]

Join Stanford Onco-nephrology conferences!
Monthly conference Thurs at noon PST

https://t.co/bGbWn57BHi